81_FR_63371 81 FR 63193 - National Human Genome Research Institute; Notice of Closed Meeting

81 FR 63193 - National Human Genome Research Institute; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 178 (September 14, 2016)

Page Range63193-63193
FR Document2016-22024

Federal Register, Volume 81 Issue 178 (Wednesday, September 14, 2016) 
[Federal Register Volume 81, Number 178 (Wednesday, September 14, 2016)]
[Notices]
[Page 63193]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-22024]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Human Genome Research Institute; Notice of Closed 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Human Genome Research Institute 
Initial Review Group; Genome Research Review Committee, GNOM-G CEGS.
    Date: November 15-16, 2016.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Gaithersburg Marriott Washingtonian Center, 9751 Lakeside 
Ballroom, Washingtonian Blvd., Gaithersburg, MD 20878.
    Contact Person: Rudy Pozzatti, Ph.D., Scientific Review Officer, 
Scientific Review Branch, National Human Genome Research Institute, 
5635 Fishers Lane, Suite 4076, MSC 9306, Rockville, MD 20852, (301) 
402-0838, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human 
Genome Research, National Institutes of Health, HHS)

    Dated: September 7, 2016.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-22024 Filed 9-13-16; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 81, No. 178 / Wednesday, September 14, 2016 / Notices 63193 The meeting will be closed to the Group; Genome Research Review Committee, Name of Committee: National Institute on public in accordance with the GNOM–G CEGS. Drug Abuse Special Emphasis Panel; Cutting- provisions set forth in sections Date: November 15–16, 2016. Edge Basic Research Awards (CEBRA) (R21). Time: 8:00 a.m. to 5:00 p.m. Date: October 25–26, 2016. 552b(c)(4) and 552b(c)(6), title 5 U.S.C., Agenda: To review and evaluate grant Time: 8:00 a.m. to 5:00 p.m. as amended. The grant applications and applications. Agenda: To review and evaluate grant the discussions could disclose Place: Gaithersburg Marriott applications. confidential trade secrets or commercial Washingtonian Center, 9751 Lakeside Place: Hilton Garden Inn Bethesda, 7301 property such as patentable material, Ballroom, Washingtonian Blvd., Waverly Street, Bethesda, MD 20814. and personal information concerning Gaithersburg, MD 20878. Contact Person: Jose F. Ruiz, Ph.D., individuals associated with the grant Contact Person: Rudy Pozzatti, Ph.D., Scientific Review Officer, Office of applications, the disclosure of which Scientific Review Officer, Scientific Review Extramural Policy and Review, National Branch, National Human Genome Research Institute on Drug Abuse, NIH, Room 4228, would constitute a clearly unwarranted Institute, 5635 Fishers Lane, Suite 4076, MSC MSC 9550, 6001 Executive Blvd., Bethesda, invasion of personal privacy. MD 20892–9550, (301) 301–827–5842, 9306, Rockville, MD 20852, (301) 402–0838, Name of Committee: National Institute on pozzattr@mail.nih.gov. ruizjf@nida.nih.gov. Aging Special Emphasis Panel; Alzheimer’s Name of Committee: National Institute on (Catalogue of Federal Domestic Assistance Prevention Initiative. Drug Abuse Special Emphasis Panel; NIH Program Nos. 93.172, Human Genome Date: September 29, 2016. Pathway to Independence Award (K99/R00). Research, National Institutes of Health, HHS) Time: 8:00 p.m. to 8:30 p.m. Date: October 26, 2016. Agenda: To review and evaluate grant Dated: September 7, 2016. Time: 8:00 a.m. to 3:00 p.m. applications. Sylvia L. Neal, Agenda: To review and evaluate grant Place: Doubletree Hotel Bethesda Program Analyst, Office of Federal Advisory applications. (Formerly Holiday Inn Select), 8120 Committee Policy. Place: Courtyard by Marriott, 5520 Wisconsin Avenue, Bethesda, MD 20814. Wisconsin Avenue, Chevy Chase, MD 20815. Contact Person: Jeannette L. Johnson, [FR Doc. 2016–22024 Filed 9–13–16; 8:45 am] Contact Person: Susan O. McGuire, Ph.D., Ph.D., National Institute on Aging, National BILLING CODE 4140–01–P Scientific Review Officer, Office of Institutes of Health, 7201 Wisconsin Avenue, Extramural Affairs, National Institute on Suite 2W200, Bethesda, MD 20892, 301–402– Drug Abuse, National Institutes of Health, 7705, johnsonj9@nia.nih.gov. DEPARTMENT OF HEALTH AND DHHS, 6001 Executive Blvd., Room 4245, This notice is being published less than 15 HUMAN SERVICES Rockville, MD 20852, (301) 827–5817, days prior to the meeting due to the timing mcguireso@mail.nih.gov. limitations imposed by the review and National Institutes of Health Name of Committee: National Institute on funding cycle. Drug Abuse Special Emphasis Panel; NIDA (Catalogue of Federal Domestic Assistance National Institute on Drug Abuse; Mentored Clinical Scientists Development Program Nos. 93.866, Aging Research, Notice of Closed Meetings Program Award in Drug Abuse and National Institutes of Health, HHS) Addiction (K12). Pursuant to section 10(d) of the Date: October 26, 2016. Dated: September 8, 2016. Time: 3:00 p.m. to 5:00 p.m. Federal Advisory Committee Act, as Melanie J. Gray, Agenda: To review and evaluate grant amended (5 U.S.C. App), notice is Program Analyst, Office of Federal Advisory applications. hereby given of the following meetings. Place: Courtyard by Marriott, 5520 Committee Policy. [FR Doc. 2016–22021 Filed 9–13–16; 8:45 am] The meetings will be closed to the Wisconsin Avenue, Chevy Chase, MD 20815. public in accordance with the Contact Person: Susan O. McGuire, Ph.D., BILLING CODE 4140–01–P provisions set forth in sections Scientific Review Officer, Office of 552b(c)(4) and 552b(c)(6), title 5 U.S.C., Extramural Affairs, National Institute on Drug Abuse, National Institutes of Health, DEPARTMENT OF HEALTH AND as amended. The grant applications and DHHS, 6001 Executive Blvd., Room 4245, HUMAN SERVICES the discussions could disclose Rockville, MD 20852, (301) 827–5817, confidential trade secrets or commercial mcguireso@mail.nih.gov. National Institutes of Health property such as patentable material, (Catalogue of Federal Domestic Assistance and personal information concerning Program Nos.: 93.279, Drug Abuse and National Human Genome Research individuals associated with the grant Addiction Research Programs, National Institute; Notice of Closed Meeting applications, the disclosure of which Institutes of Health, HHS) Pursuant to section 10(d) of the would constitute a clearly unwarranted Dated: September 8, 2016. Federal Advisory Committee Act, as invasion of personal privacy. Natasha M. Copeland, amended (5 U.S.C. App.), notice is Name of Committee: National Institute on Program Analyst, Office of Federal Advisory hereby given of the following meeting. Drug Abuse Special Emphasis Panel; NIDA Committee Policy. The meeting will be closed to the Research Education Program for Clinical [FR Doc. 2016–22020 Filed 9–13–16; 8:45 am] public in accordance with the Researchers and Clinicians (R25). BILLING CODE 4140–01–P provisions set forth in sections Date: October 6, 2016. Time: 10:00 a.m. to 12:00 p.m. 552b(c)(4) and 552b(c)(6), title 5 U.S.C., Agenda: To review and evaluate grant as amended. The grant applications and applications. DEPARTMENT OF HEALTH AND the discussions could disclose Place: National Institutes of Health, HUMAN SERVICES confidential trade secrets or commercial Neuroscience Center, 6001 Executive asabaliauskas on DSK3SPTVN1PROD with NOTICES property such as patentable material, Boulevard, Rockville, MD 20852. (Telephone National Institutes of Health and personal information concerning Conference Call) individuals associated with the grant Contact Person: Hiromi Ono, Ph.D., National Institute of Nursing Research; applications, the disclosure of which Scientific Review Officer, Office of Notice of Closed Meetings would constitute a clearly unwarranted Extramural Affairs, National Institute on Drug Abuse, National Institutes of Health, Pursuant to section 10(d) of the invasion of personal privacy. DHHS, 6001 Executive Boulevard, Room Federal Advisory Committee Act, as Name of Committee: National Human 4238, MSC 9550, Bethesda, MD 20892, (301) amended (5 U.S.C. App.), notice is Genome Research Institute Initial Review 827–5820, hiromi.ono@nih.gov. hereby given of the following meetings. VerDate Sep<11>2014 20:55 Sep 13, 2016 Jkt 238001 PO 00000 Frm 00028 Fmt 4703 Sfmt 4703 E:\FR\FM\14SEN1.SGM 14SEN1


Document Created: 2016-09-14 02:27:34
Document Modified: 2016-09-14 02:27:34
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesNovember 15-16, 2016.
FR Citation81 FR 63193 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR